Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20111
20131
20141
20172
20181
20191
20203
20212
20222
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting3
Terminated3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Children's Oncology Group2
Aptose Biosciences Inc.1
Clinical Hub for Interventional Research (CHOIR)1
Cogent Biosciences, Inc.1
Eli Lilly and Company1
Ellipses Pharma1
Janssen Research & Development, LLC1
Kirby Institute1
Otsuka Australia Pharmaceutical Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic21
Myelodysplastic Syndromes16
Leukemia, Myeloid, Acute12
Myeloproliferative Disorders5
Leukemia4
Recurrence4
Anemia, Refractory, with Excess of Blasts3
Leukemia, Myelomonocytic, Juvenile3
Anemia, Refractory2
Burkitt Lymphoma2

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.